Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
Aldaoud
Ali
A
dr.aldaoud.ali@t-online.de
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077610:Bexarotene; D006801:Humans; D017730:Ki-1 Antigen / Q000378:metabolism; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*; D013997:Time Factors
D000970:Antineoplastic Agents; D017730:Ki-1 Antigen; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene